SMMT

About Summit Therapeutics Inc. Common Stock (SMMT) Stock

Summit Therapeutics Inc. Common Stock (SMMT) closed the 2026-09-18 session at $17.85, up 0.73% versus the previous close (+0.13). The stock opened at $17.73 and traded between $17.31 and $17.87 during that session. Session trading volume was 13.1M shares. The volume-weighted average price (VWAP) is $17.79.

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Summit Therapeutics Inc. Common Stock has a market capitalization of $14.24 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SMMT is listed on the XNAS exchange. The company employs approximately 265 people. Summit Therapeutics Inc. Common Stock is headquartered in MIAMI, FL. The recorded listing date is 2015-03-05.

On this page you can find market SMMT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.